Gain Therapeutics Inc（GANX）價格預測GANXGain Therapeutics Inc

Alphio's GANX stock price prediction model matches the current Gain Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.02 (+0.70%). The 1-week path is $1.01 (+0.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Gain Therapeutics Inc (GANX) is trading at $1.13, significantly below its 52-week high of $4.34, indicating a potential undervaluation. However, the RSI is at a low 25.78, suggesting the stock is oversold, which could indicate a buying opportunity. The company has reported a narrower loss of $4.67 million in Q2 2026, down from $5.81 million a year ago, showing improved financial performance. The main risk is the ongoing negative earnings trend, with a projected EPS of -0.13 for the next earnings report on November 11, 2026.

Gain Therapeutics Inc (GANX) last closed at $1.0099, gaining +5.15%. These facts feed the 1-day and 1-week GANX price prediction above.